title: In the public interest?
abstract: Restrictive patenting and licensing for cell-free fetal DNA testing has serious consequences for technology advances and benefits to public health.
authors: Stanford Center for Biomedical Ethics, Stanford University, Stanford, CA 94301, USA. lauren.sayres@duke.edu
authors: Lauren C
authors: LC
authors: Sayres
authors: Megan
authors: M
authors: Allyse
authors: Taylor A
authors: TA
authors: Goodspeed
authors: Mildred K
authors: MK
authors: Cho
mesh_terms: D004247:DNA / Q000097:blood*; D005260:Female; D005333:Fetus; D006801:Humans; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000191:economics / Q000379:methods*
chemical_list: D004247:DNA